Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Bladder Cancer

Free Subscription 31.08.2020 1 Actas Urol Esp 1 Aktuelle Urol 1 Biomed Pharmacother 1 BMC Cancer 1 Cancer Cell Int 2 Cancer Med 1 Cancer Treat Rev 1 Cancers (Basel) 1 Clin Imaging 1 Clin Transl Oncol 1 Diagnostics (Basel) 1 Eur J Med Chem 1 Eur Radiol 2 Eur Urol 1 Eur Urol Oncol 1 F1000Res 1 Front Chem 1 Front Nutr 3 Front Oncol 1 Hinyokika Kiyo 1 Int Braz J Urol 1 Int J Clin Oncol 1 Int J Environ Res Public Health 2 Int J Mol Sci 1 J Am Acad Dermatol 1 J Biomol Tech 1 J Clin Pharmacol 1 J Mol Histol 8 J Urol 1 Mol Cancer Ther 1 Neoplasma 1 Oncol Rep 3 PLoS One 1 Research (Wash D C) 2 Rev Med Liege 1 SN Compr Clin Med 1 Urol Int 1 Urology 1 Zhonghua Yi Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Actas Urol Esp

1. GOMEZ DEL CANIZO C, Rodriguez-Izquierdo Jimenez M, Pena Vallejo E, Duarte Ojeda JM, et al
   New immunotherapies for high-risk non-muscle invasive bladder cancer: Current state and future perspectives.
   Actas Urol Esp. 2020 Aug 24. pii: S0210-4806(20)30158.
   PubMed         Abstract available
   
   

   
   Aktuelle Urol

2. 
   
   Aktuelle Urol. 2020;51:406-410.
   PubMed        
   
   

   
   Biomed Pharmacother

3. JIANG L, Song H, Guo H, Wang C, et al
   Retraction notice to "Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106" [Biomed. Pharmacother. 107 (2018) 1583-1590].
   Biomed Pharmacother. 2020 Aug 22:110634. doi: 10.1016/j.biopha.2020.110634.
   PubMed        
   
   

   
   BMC Cancer

4. PORSERUD A, Karlsson P, Rydwik E, Aly M, et al
   The CanMoRe trial - evaluating the effects of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer: the study protocol of a randomised controlled trial.
   BMC Cancer. 2020;20:805.
   PubMed         Abstract available
   
   

   
   Cancer Cell Int

5. LIN J, Yang J, Xu X, Wang Y, et al
   A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts.
   Cancer Cell Int. 2020;20:402.
   PubMed         Abstract available
   
   

   
   Cancer Med

6. RUSSELL B, Hemelrijck MV, Gardmark T, Holmberg L, et al
   A mediation analysis to explain socio-economic differences in bladder cancer survival.
   Cancer Med. 2020 Aug 26. doi: 10.1002/cam4.3418.
   PubMed         Abstract available
   
   
7. WANG Y, Chen L, Yu M, Fang Y, et al
   Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer.
   Cancer Med. 2020 Aug 25. doi: 10.1002/cam4.3400.
   PubMed         Abstract available
   
   

   
   Cancer Treat Rev

8. KOUFOPOULOU M, Miranda PAP, Kazmierska P, Deshpande S, et al
   Clinical evidence for the first-line treatment of advanced urothelial carcinoma: Current paradigms and emerging treatment options.
   Cancer Treat Rev. 2020;89:102072.
   PubMed         Abstract available
   
   

   
   Cancers (Basel)

9. WANG YT, Shi T, Srivastava S, Kagan J, et al
   Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer.
   Cancers (Basel). 2020;12.
   PubMed         Abstract available
   
   

   
   Clin Imaging

10. LEE SC, Geannette CS
    Osteomyelitis and septic arthritis after Mycobacterium Bovis BCG Therapy for Urinary Bladder Cancer.
    Clin Imaging. 2020;68:179-183.
    PubMed         Abstract available
    
    

    
    Clin Transl Oncol

11. GARDE-GARCIA H, Redondo-Gonzalez E, Maestro-de Las Casas M, Fernandez-Perez C, et al
    Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications.
    Clin Transl Oncol. 2020 Aug 24. pii: 10.1007/s12094-020-02476.
    PubMed         Abstract available
    
    

    
    Diagnostics (Basel)

12. KOSLINSKI P, Pluskota R, Madra-Gackowska K, Gackowski M, et al
    Comparison of Pteridine Normalization Methods in Urine for Detection of Bladder Cancer.
    Diagnostics (Basel). 2020;10.
    PubMed         Abstract available
    
    

    
    Eur J Med Chem

13. CHEN JN, Li T, Cheng L, Qin TS, et al
    Synthesis and in vitro anti-bladder cancer activity evaluation of quinazolinyl-arylurea derivatives.
    Eur J Med Chem. 2020;205:112661.
    PubMed         Abstract available
    
    

    
    Eur Radiol

14. ARITA Y, Shigeta K, Akita H, Suzuki T, et al
    Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
    Eur Radiol. 2020 Aug 23. pii: 10.1007/s00330-020-07153.
    PubMed         Abstract available
    
    

    
    Eur Urol

15. FLIPPOT R, Loriot Y
    The FGFR3 Story in Bladder Cancer: Another Piece of the Puzzle?
    Eur Urol. 2020 Aug 24. pii: S0302-2838(20)30633.
    PubMed        
    
    
16. VILA-REYES H, DeCastro GJ, McKiernan JM
    Re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscl
    Eur Urol. 2020 Aug 20. pii: S0302-2838(20)30623.
    PubMed        
    
    

    
    Eur Urol Oncol

17. PEDERZOLI F, Bandini M, Marandino L, Raggi D, et al
    Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm?
    Eur Urol Oncol. 2020 Aug 23. pii: S2588-9311(20)30121.
    PubMed         Abstract available
    
    

    
    F1000Res

18. LOPES RI, Mello MF, Lorenzo AJ
    Recent advances in pediatric bladder malignancies.
    F1000Res. 2020;9.
    PubMed         Abstract available
    
    

    
    Front Chem

19. PANE K, Mirabelli P, Coppola L, Illiano E, et al
    New Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis.
    Front Chem. 2020;8:600.
    PubMed         Abstract available
    
    

    
    Front Nutr

20. XU X
    Dairy Product Consumption and Bladder Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cohort.
    Front Nutr. 2020;7:97.
    PubMed         Abstract available
    
    

    
    Front Oncol

21. XU C, Sun M, Zhang X, Xu Z, et al
    Activation of Glucocorticoid Receptor Inhibits the Stem-Like Properties of Bladder Cancer via Inactivating the beta-Catenin Pathway.
    Front Oncol. 2020;10:1332.
    PubMed         Abstract available
    
    
22. XIE Q, Tang T, Pang J, Xu J, et al
    LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT.
    Front Oncol. 2020;10:1234.
    PubMed         Abstract available
    
    
23. LI F, Teng H, Liu M, Liu B, et al
    Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer.
    Front Oncol. 2020;10:1302.
    PubMed         Abstract available
    
    

    
    Hinyokika Kiyo

24. NISHIKAWA T, Sugino Y, Owa S, Kitano G, et al
    [Neoajuvant Chemotherapy with Gemcitabine and Cisplatin Plus S-1 for Primary Female Urethral Adenocarcinoma].
    Hinyokika Kiyo. 2020;66:115-119.
    PubMed         Abstract available
    
    

    
    Int Braz J Urol

25. KAVARIC P, Eldin S, Nenad R, Dragan P, et al
    Modified wallace anastomotic technique reduces ureteroenteric stricture rates after ileal conduit urinary diversion.
    Int Braz J Urol. 2020;46:446-455.
    PubMed         Abstract available
    
    

    
    Int J Clin Oncol

26. OSAWA T, Wei JT, Abe T, Honda M, et al
    Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index.
    Int J Clin Oncol. 2020 Aug 24. pii: 10.1007/s10147-020-01770.
    PubMed         Abstract available
    
    

    
    Int J Environ Res Public Health

27. LI CC, Hsieh MJ, Wang SS, Hung SC, et al
    Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
    Int J Environ Res Public Health. 2020;17.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

28. HAYASHI T, Fujita K, Hayashi Y, Hatano K, et al
    Mutational Landscape and Environmental Effects in Bladder Cancer.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available
    
    
29. ZVEREVA M, Pisarev E, Hosen I, Kisil O, et al
    Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

30. GOYAL A, O'Leary D, Goyal K, Patel K, et al
    Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer: a systematic review and meta-analysis.
    J Am Acad Dermatol. 2020 Aug 18. pii: S0190-9622(20)32444.
    PubMed         Abstract available
    
    

    
    J Biomol Tech

31. DHUNGANA S, Munjoma N, Isaac G, Gethings L, et al
    A Rapid and Comprehensive Targeted Approach for Investigating the Lipidome of Bladder Cancer Subjects.
    J Biomol Tech. 2020;31.
    PubMed         Abstract available
    
    

    
    J Clin Pharmacol

32. GARCIA M, Arteche-Martinez U, Lertxundi U, Aguirre C, et al
    SGLT2 Inhibitors and Bladder Cancer: Analysis of Cases Reported in the European Pharmacovigilance Database.
    J Clin Pharmacol. 2020 Aug 21. doi: 10.1002/jcph.1722.
    PubMed         Abstract available
    
    

    
    J Mol Histol

33. ZHOU Y, Song X, Li X, Li H, et al
    Serum LUCAT1 implicates the pathogenesis of muscle-invasive bladder cancer via targeting miR-199a-5p and miR-199b-5p.
    J Mol Histol. 2020 Aug 25. pii: 10.1007/s10735-020-09907.
    PubMed         Abstract available
    
    

    
    J Urol

34. CHANG SS
    Re: Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2020 Aug 21:101097JU000000000000126001.
    PubMed        
    
    
35. CHANG SS
    Re: Cigarette Smoking is Associated with Adverse Pathological Response and Increased Disease Recurrence amongst Patients with Muscle-Invasive Bladder Cancer Treated with Cisplatin-Based Neoadjuvant Chemotherapy and Radical Cystectomy: A Single-Centre
    J Urol. 2020 Aug 21:101097JU000000000000126002.
    PubMed        
    
    
36. CHANG SS
    Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated with Neoadjuvant Chemotherapy.
    J Urol. 2020;204:184.
    PubMed        
    
    
37. GARNIER S, Vendrell J, Boillot B, Karsenty G, et al
    Malignancy after Augmentation Enterocystoplasty: A Nationwide Study of Natural History, Prognosis and Oncogene Panel Analysis.
    J Urol. 2020 Jan 20:101097JU0000000000000752. doi: 10.1097/JU.0000000000000752.
    PubMed         Abstract available
    
    
38. SZYMANSKI KM, Misseri R, Whittam B, Hollowell N, et al
    Additional Surgeries after Bladder Augmentation in Patients with Spina Bifida in the 21st Century.
    J Urol. 2020;203:1207-1213.
    PubMed         Abstract available
    
    
39. FOERSTER B, Abufaraj M, Petros F, Azizi M, et al
    Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
    J Urol. 2020;203:1101-1108.
    PubMed         Abstract available
    
    
40. CHANG SS
    Re: Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial.
    J Urol. 2020 Aug 21:101097JU0000000000001260. doi: 10.1097/JU.0000000000001260.
    PubMed        
    
    
41. ORESTA B, Braga D, Lazzeri M, Frego N, et al
    The Microbiome of Catheter-Collected Urine in Males with Bladder Cancer according to Disease Stage.
    J Urol. 2020 Aug 28:101097JU0000000000001336. doi: 10.1097/JU.0000000000001336.
    PubMed         Abstract available
    
    

    
    Mol Cancer Ther

42. GLEAVE ME, Kawai Y, Imada K, Akamatsu S, et al
    Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion and Survival of Bladder Cancer.
    Mol Cancer Ther. 2020 Aug 26. pii: 1535-7163.MCT-19-1031.
    PubMed         Abstract available
    
    

    
    Neoplasma

43. YANG F, Guo Z, He C, Qing L, et al
    Cancer-associated fibroblasts promote cell proliferation and invasion via paracrine Wnt/IL1beta signaling pathway in human bladder cancer.
    Neoplasma. 2020 Aug 28. pii: 200202N101. doi: 10.4149/neo_2020_200202.
    PubMed         Abstract available
    
    

    
    Oncol Rep

44. LIU J, Zhao Z, Sun Z, Liu C, et al
    Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation.
    Oncol Rep. 2020;43:562-570.
    PubMed         Abstract available
    
    

    
    PLoS One

45. SANTOS-SANCHEZ V, Cordoba-Dona JA, Viciana F, Escolar-Pujolar A, et al
    Geographical variations in cancer mortality and social inequalities in southern Spain (Andalusia). 2002-2013.
    PLoS One. 2020;15:e0233397.
    PubMed         Abstract available
    
    
46. HUTTANUS HM, Vu T, Guruli G, Tracey A, et al
    Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer.
    PLoS One. 2020;15:e0237070.
    PubMed         Abstract available
    
    
47. MEHUS AA, Bergum N, Knutson P, Shrestha S, et al
    Activation of PPARgamma and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells.
    PLoS One. 2020;15:e0237976.
    PubMed         Abstract available
    
    

    
    Research (Wash D C)

48. GUO H, Li F, Qiu H, Xu W, et al
    Synergistically Enhanced Mucoadhesive and Penetrable Polypeptide Nanogel for Efficient Drug Delivery to Orthotopic Bladder Cancer.
    Research (Wash D C). 2020;2020:8970135.
    PubMed         Abstract available
    
    

    
    Rev Med Liege

49. CHANAL E, Bouleftour W, Dridi M, Heritier P, et al
    [A complex case of miliary pulmonary tuberculosis following intravesical BCG therapy].
    Rev Med Liege. 2020;75.
    PubMed         Abstract available
    
    
50. ANDRIANNE C, Dewandre M, El Hachem G, Burkhard F, et al
    [Metastase from lobular breast carcinoma on the ileal patch of augmentation].
    Rev Med Liege. 2020;75.
    PubMed         Abstract available
    
    

    
    SN Compr Clin Med

51. LEESON CE, Ismail A, Hashad MM, Elmansy H, et al
    Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19.
    SN Compr Clin Med. 2020 Aug 18:1-5. doi: 10.1007/s42399-020-00461.
    PubMed         Abstract available
    
    

    
    Urol Int

52. MAISCH P, Retz M, Gschwend JE, Koll F, et al
    Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument.
    Urol Int. 2020 Aug 21:1-10. doi: 10.1159/000509431.
    PubMed         Abstract available
    
    

    
    Urology

53. GUPTA N, Rasmussen SEVP, Haney N, Smith A, et al
    Understanding psychosocial and sexual health concerns among women with bladder cancer undergoing radical cystectomy.
    Urology. 2020 Aug 24. pii: S0090-4295(20)31008.
    PubMed         Abstract available
    
    

    
    Zhonghua Yi Xue Za Zhi

54. ZHAO QX, Yang FY, Chen D, Wu LY, et al
    [Application of Endo-GIA stapler in laparoscopic radicalcystectomy].
    Zhonghua Yi Xue Za Zhi. 2020;100:1872-1876.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: